BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31744674)

  • 21. Novel synthetic baicalein derivatives caused apoptosis and activated AMP-activated protein kinase in human tumor cells.
    Ding D; Zhang B; Meng T; Ma Y; Wang X; Peng H; Shen J
    Org Biomol Chem; 2011 Nov; 9(21):7287-91. PubMed ID: 21901221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of novel adenosine monophosphate-activated protein kinase activators.
    Guh JH; Chang WL; Yang J; Lee SL; Wei S; Wang D; Kulp SK; Chen CS
    J Med Chem; 2010 Mar; 53(6):2552-61. PubMed ID: 20170185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Novel Alkene Oxindole Derivatives As Orally Efficacious AMP-Activated Protein Kinase Activators.
    Yu LF; Li YY; Su MB; Zhang M; Zhang W; Zhang LN; Pang T; Zhang RT; Liu B; Li JY; Li J; Nan FJ
    ACS Med Chem Lett; 2013 May; 4(5):475-80. PubMed ID: 24900695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sanguinarine is an allosteric activator of AMP-activated protein kinase.
    Choi J; He N; Sung MK; Yang Y; Yoon S
    Biochem Biophys Res Commun; 2011 Sep; 413(2):259-63. PubMed ID: 21884681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of 3,5-Dimethylpyridin-4(1H)-one Derivatives as Activators of AMP-Activated Protein Kinase (AMPK).
    Kuramoto K; Sawada Y; Ishibashi N; Yamada T; Nagashima T; Shin T
    Chem Pharm Bull (Tokyo); 2020; 68(1):77-90. PubMed ID: 31902903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of action of compound-13: an α1-selective small molecule activator of AMPK.
    Hunter RW; Foretz M; Bultot L; Fullerton MD; Deak M; Ross FA; Hawley SA; Shpiro N; Viollet B; Barron D; Kemp BE; Steinberg GR; Hardie DG; Sakamoto K
    Chem Biol; 2014 Jul; 21(7):866-79. PubMed ID: 25036776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Direct Activator of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by Structure-Based Virtual Screening and Molecular Docking Approach.
    Huang T; Sun J; Zhou S; Gao J; Liu Y
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28665353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases.
    Srivastava RA; Pinkosky SL; Filippov S; Hanselman JC; Cramer CT; Newton RS
    J Lipid Res; 2012 Dec; 53(12):2490-514. PubMed ID: 22798688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric Modulation of AMPK Enzymatic Activity: In Vitro Characterization.
    Ward J; Reyes AR; Kurumbail RG
    Methods Enzymol; 2017; 587():481-509. PubMed ID: 28253974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imidazo[1,2-a]pyridine Derivatives as AMPK Activators: Synthesis, Structure-Activity Relationships, and Regulation of Reactive Oxygen Species in Renal Fibroblasts.
    Wu S; Xiao Z; Wei J; Zhang L; Cao Y; Chen Z; Li Q; Hu G
    ChemMedChem; 2023 Apr; 18(8):e202200696. PubMed ID: 36750404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promise and challenges for direct small molecule AMPK activators.
    Olivier S; Foretz M; Viollet B
    Biochem Pharmacol; 2018 Jul; 153():147-158. PubMed ID: 29408352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMPK activators: mechanisms of action and physiological activities.
    Kim J; Yang G; Kim Y; Kim J; Ha J
    Exp Mol Med; 2016 Apr; 48(4):e224. PubMed ID: 27034026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and SAR development of thienopyridones: a class of small molecule AMPK activators.
    Zhao G; Iyengar RR; Judd AS; Cool B; Chiou W; Kifle L; Frevert E; Sham H; Kym PR
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3254-7. PubMed ID: 17451949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of Metabolic and Renal Clearance in a Series of Indole Acid Direct Activators of 5'-Adenosine Monophosphate-Activated Protein Kinase (AMPK).
    Edmonds DJ; Kung DW; Kalgutkar AS; Filipski KJ; Ebner DC; Cabral S; Smith AC; Aspnes GE; Bhattacharya SK; Borzilleri KA; Brown JA; Calabrese MF; Caspers NL; Cokorinos EC; Conn EL; Dowling MS; Eng H; Feng B; Fernando DP; Genung NE; Herr M; Kurumbail RG; Lavergne SY; Lee EC; Li Q; Mathialagan S; Miller RA; Panteleev J; Polivkova J; Rajamohan F; Reyes AR; Salatto CT; Shavnya A; Thuma BA; Tu M; Ward J; Withka JM; Xiao J; Cameron KO
    J Med Chem; 2018 Mar; 61(6):2372-2383. PubMed ID: 29466005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and hit-to-lead optimization of novel allosteric glucokinase activators.
    Lang M; Seifert MH; Wolf KK; Aschenbrenner A; Baumgartner R; Wieber T; Trentinaglia V; Blisse M; Tajima N; Yamashita T; Vitt D; Noda H
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5417-22. PubMed ID: 21813277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine monophosphate-activated kinase and its key role in catabolism: structure, regulation, biological activity, and pharmacological activation.
    Krishan S; Richardson DR; Sahni S
    Mol Pharmacol; 2015; 87(3):363-77. PubMed ID: 25422142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics.
    Arkwright RT; Deshmukh R; Adapa N; Stevens R; Zonder E; Zhang Z; Farshi P; Ahmed RS; El-Banna HA; Chan TH; Dou QP
    Anticancer Agents Med Chem; 2015; 15(5):657-71. PubMed ID: 25511514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric regulation of AMP-activated protein kinase by adenylate nucleotides and small-molecule drugs.
    de Souza Almeida Matos AL; Oakhill JS; Moreira J; Loh K; Galic S; Scott JW
    Biochem Soc Trans; 2019 Apr; 47(2):733-741. PubMed ID: 31000529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy.
    Cameron KO; Kung DW; Kalgutkar AS; Kurumbail RG; Miller R; Salatto CT; Ward J; Withka JM; Bhattacharya SK; Boehm M; Borzilleri KA; Brown JA; Calabrese M; Caspers NL; Cokorinos E; Conn EL; Dowling MS; Edmonds DJ; Eng H; Fernando DP; Frisbie R; Hepworth D; Landro J; Mao Y; Rajamohan F; Reyes AR; Rose CR; Ryder T; Shavnya A; Smith AC; Tu M; Wolford AC; Xiao J
    J Med Chem; 2016 Sep; 59(17):8068-81. PubMed ID: 27490827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computer-aided drug design for AMP-activated protein kinase activators.
    Wang Z; Huo J; Sun L; Wang Y; Jin H; Yu H; Zhang L; Zhou L
    Curr Comput Aided Drug Des; 2011 Sep; 7(3):214-27. PubMed ID: 21595631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.